Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 2/20 | 0.34 |
| ▸ | CA2 | P00918 | 2/20 | 0.34 |
| ▸ | CA12 | O43570 | 1/20 | 0.34 |
| ▸ | CA7 | P43166 | 1/20 | 0.34 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.31 |
| ▸ | PPARA | Q07869 | 2/20 | 0.30 |
| ▸ | FDPS | P14324 | 1/20 | 0.30 |
| ▸ | NPC1 | O15118 | 1/20 | 0.30 |
| ▸ | RAB9A | P51151 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17520383 | 0.91 | EPHX1 (0.37) | CA1CA2EPHX1PPARAFDPS | |
| SCHEMBL17520395 | 0.91 | EPHX1 (0.37) | CA1CA2EPHX1PPARAFDPS | |
| SCHEMBL13164464 | 0.86 | ALDH1A1 (0.39) | ALDH1A1 | |
| SCHEMBL10888401 | 0.84 | CA1 (0.41) | CA1CA2CA12CA7CA14 | |
| SCHEMBL17520385 | 0.81 | DUT (0.35) | ALDH1A1 | |
| SCHEMBL1726736 | 0.80 | CA2 (0.35) | CA1CA2CA12CA7CA14 | |
| SCHEMBL17520404 | 0.78 | DUT (0.36) | ALDH1A1 | |
| SCHEMBL10486694 | 0.77 | CA1 (0.39) | CA1CA2CA12CA7CA14 | |
| SCHEMBL23872397 | 0.77 | GRIA1 (0.38) | CA1CA2CA12CA7CA14 | |
| SCHEMBL19271990 | 0.77 | EPHX1 (0.36) | CA1CA2EPHX1PPARAFDPS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2012058125-A1 | INHIBITORS OF HEPATITIS C VIRUS | PRESIDIO PHARMACEUTICALS, INC. (US) | 2012-05-03 | — | — | WO | disclosed |